Apel A, Moshe Y, Ofran Y, Gural A, et al. Venetoclax combinations induce high response rates in newly diagnosed Acute Myeloid Leukemia patients ineligible for intensive chemotherapy in routine practice. Am J Hematol 2021 Apr 9. doi: 10.1002/ajh.26190.
PMID: 33836555